fda compounding semaglutide enforcement 2025 news What Patients Need to Know About the GLP-1 Policy Changes Patients struggle as compounded GLP-1

The shortage has created new access barriers for patients previously using or wishing to initiate these products for glycemic management, weight loss, and/or cardiovascular risk reduction

Retatrutide is a laboratory designed, chemically modified peptide developed within Eli Lillys pharmaceutical research programme

Although blood pressure lowering is an established mechanism for reducing MACE, the magnitude seen with GLP-1RAs is likely insufficient to explain the full extent of CV benefit (66)

Key takeaways Semaglutide is the main ingredient in Ozempic, Rybelsus, and Wegovy and has become increasingly popular for weight loss

If you choose plant-based milk, take a quick look at the nutrition label